Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-25

Clinical Trial Update: The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the effect of Soliqua on glucose variability in adults with Type 2 diabetes in South Asian patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Soliqua

Snippet

Sponsor: LMC Diabetes & Endocrinology Ltd. | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED